Effect of neonatal phototherapy on melanocytic nevus count in children

Archives of Dermatology

Volumn 142, Issue 12, 2006, Pages 1599-1604

  Matichard, Emmanuelle ^a   Le Hénanff, Anne ^a   Sanders, Alfred ^a   Leguyadec, Jocelyne ^b   Crickx, Beatrice ^a   Descamps, Vincent ^a,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b Malakoff Public School   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLUE LIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELANOCYTIC NEVUS; PHENOTYPE; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SUN EXPOSURE; UNIVERSITY HOSPITAL;

AGE FACTORS; CASE-CONTROL STUDIES; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; MELANOMA; NEVUS, PIGMENTED; PARIS; PHOTOCHEMOTHERAPY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 33845694443     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.12.1599     Document Type: Article

References (27)

1. Dreno B, Wallon-Dumont G. Epidemiology of melanoma [in French]. Presse Med. 2003;32:30-32.
2. Youl P, Aitken J, Hayward N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer. 2002;98:92-98.
3. Grulich AE, Bataille V, Swerdlow AJ, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer. 1996;67:485-491.
4. Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000;88:2703-2710.
5. Swerdlow AJ, English J, Mackie RM, O'Doherty CJ, Hunter JA, Clark J. Benign naevi associated with high risk of melanoma [letter]. Lancet. 1984;2:168.
6. Luther H, Altmeyer P, Garbe C, et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol. 1996;132:1473-1478.
7. Pope DJ, Sorahan T, Marsden J, Ball PM, Grimley RP, Peck IM; The West Midlands, United Kingdom, Mole Study. Benign pigmented nevi in children: prevalence and associated factors. Arch Dermatol. 1992;128:1201-1216.
8. Gallagher RP, Mclean DI, Yang CP, et al; The Vancouver Mole Study. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children: similarities to melanoma. Arch Dermatol. 1990;126:770-776.
9. Setlow RB. Spectral regions contributing to melanoma: a personal view. J Investig Dermatol Symp Proc. 1999;4:46-49.
10. Findlay GH. Neonatal phototherapy for jaundice: a dermatological assessment. Clin Exp Dermatol. 1987;12:112-113.
11. Tan KL. Management of neonatal jaundice. Singapore Med J. 1989;30:393-395.
12. McDonagh AF, Palma LA, Lightner DA. Blue light and bilirubin excretion. Science. 1980;208:145-151.
13. Straver B, Hassing MB, von den Knapp MS, Gemke RJ. Kernicterus in a full-term male infant a few days old. Ned Tijdschr Geneeskd. 2002;146:909-913.
14. Porto SO. In vitro and in vivo studies on the effect of phototherapy upon bilirubin. Birth Defects Orig Artic Ser. 1970;6:83-89.
15. Granati B, Largajolli G, Rubaltelli FF, Pollazzon P, Bottos M, Sartori E. Efficacy and safety of the "integral" phototherapy for neonatal hyperbilirubinemia: results of a follow-up at 6 years of age. Clin Pediatr (Phila). 1984;23:483-486.
16. Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics. 1990;85:455-463.
17. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Effect of phototherapy for neonatal jaundice on cognitive performance. J Perinatol. 1994;14:23-28.
18. Itoh S, Onishi S, Isobe K, Manabe M, Yamakawa T. Wavelength dependence of the geometric and structural photoisomerization of bilirubin bound to human serum albumin. Biol Neonate. 1987;51:10-17.
19. MacKie RM, English J, Aitchison TC, Fitzsimons CP, Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985;113:167-174.
20. Breitbart M, Garbe C, Buttner P, et al. Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma: a case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol. 1997;77:374-378.
21. Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet. 1994;344:1529-1532.
22. Nguyen TD, Siskind V, Green L, Frost C, Green A. Ultraviolet radiation, melanocytic naevi and their dose-response relationship. Br J Dermatol. 1997;137:91-95.
23. Green A, Siskind V, Green L. The incidence of melanocytic naevi in adolescent children in Queensland, Australia. Melanoma Res. 1995;5:155-160.
24. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer. 2003;97:628-638.
25. Dontsov AE, Glickman RD, Ostrovsky MA. Retinal pigment epithelium pigment granules stimulate the photo-oxidation of unsaturated fatty acids. Free Radic Biol Med. 1999;26:1436-1446.
26. Holbrook KA, Sybert VP. Basic science: embryogenesis of the skin. In: Schachner LA, Hansson RC, eds. Pediatric Dermatology. New York, NY: Churchill Livingstone Inc; 1988.
27. Berg P, Lindelof B. Is phototherapy in neonates a risk factor for malignant melanoma development? Arch Pediatr Adolesc Med. 1997;151:1185-1187.